Provided by Tiger Trade Technology Pte. Ltd.

Stoke Therapeutics, Inc.

32.32
+0.03000.09%
Post-market: 32.320.00000.00%16:53 EDT
Volume:562.29K
Turnover:18.18M
Market Cap:2.09B
PE:-9.70
High:32.76
Open:32.29
Low:31.16
Close:32.29
52wk High:40.22
52wk Low:18.00
Shares:64.53M
Float Shares:49.01M
Volume Ratio:0.54
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3325
EPS(LYR):-0.1163
ROE:-61.10%
ROA:-35.87%
PB:6.04
PE(LYR):-277.99

Loading ...

Stoke Therapeutics appoints Clare Kahn to board of directors

Reuters
·
Apr 08

Stoke Therapeutics Appoints Clare Kahn, Ph.d., to Its Board of Directors

THOMSON REUTERS
·
Apr 08

Stoke Therapeutics CMO Barry Ticho sells STOK shares for 0.1 million

Reuters
·
Apr 04

Stoke Therapeutics FY2026 auditor changes; KPMG dismissed and EY appointed

Reuters
·
Mar 28

Stoke Therapeutics General Counsel Jonathan Allan reports STOK common stock disposal worth USD 313,000

Reuters
·
Mar 25

Stock Track | Stoke Therapeutics Soars 5.39% Intraday on Analyst Price Target Hike

Stock Track
·
Mar 20

Stoke Therapeutics Inc : Canaccord Genuity Raises Target Price to $60 From $36

THOMSON REUTERS
·
Mar 20

Stoke Therapeutics Chief Medical Officer Barry Ticho disposes of USD 460,000 in common shares

Reuters
·
Mar 20

Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (STOK), Valneva (VALN) and Protagonist Therapeutics (PTGX)

TIPRANKS
·
Mar 19

Stoke Therapeutics files automatic mixed securities shelf

TIPRANKS
·
Mar 19

Stoke Therapeutics Inc: Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Mar 19

Stoke Therapeutics Inc : Wedbush Raises Target Price to $38 From $36

THOMSON REUTERS
·
Mar 18

Stoke Therapeutics director Arthur A. Levin disposes of USD 22,264 in common shares

Reuters
·
Mar 18

Stoke Therapeutics grants 58,650 inducement stock options at USD 33.96 exercise price

Reuters
·
Mar 18

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Mar 18

Stock Track | Stoke Therapeutics Plummets 5.62% Intraday on Disappointing Earnings Forecast

Stock Track
·
Mar 17

Stoke Therapeutics Inc : Needham Raises Target Price to $40 From $35

THOMSON REUTERS
·
Mar 17

U.S. Earnings Preview: Before Market Open March 17

Dow Jones
·
Mar 17

Why Stoke Therapeutics (STOK) Is Down 11.4% After NEJM Data on Dravet Syndrome Drug - And What's Next

Simply Wall St.
·
Mar 17

Stoke Therapeutics FY2025 revenue rose 100% to USD 184.42 million as net loss narrowed 92.26% to USD 6.89 million

Reuters
·
Mar 17